dc.creatorRosselot Jaramillo, Eduardo
dc.creatorBravo L, Mireya
dc.creatorGoic Goic, Alejandro
dc.creatorHorwitz Campos, Nina
dc.creatorThambo Becker, Sergio
dc.creatorValenzuela Yuraidini, Carlos
dc.creatorSotomayor S, María Angélica
dc.date.accessioned2019-01-29T17:56:58Z
dc.date.available2019-01-29T17:56:58Z
dc.date.created2019-01-29T17:56:58Z
dc.date.issued2005
dc.identifierRevista Medica de Chile, Volumen 133, Issue 7, 2018, Pages 841-846
dc.identifier00349887
dc.identifier07176163
dc.identifierhttps://repositorio.uchile.cl/handle/2250/163899
dc.description.abstractThe use of levonorgestrel for emergency post coital contraception after rape, has raised strong and recurring discussions during 2004 and 2005 in Chile. The debate has been centered in its presumed post fertilization or anti implantation effect, that some consider an abortive action. There are no scientific evidences supporting this effect, with divergences about the ontological status of the embryo. Therefore, the use of levonorgestrel implies bioethical decisions that, in a democratic and pluralistic society, should be solved considering individual and collective responsibilities, conditions of equity and the informed autonomy of the affected women. Their moral values and their capacity to assume the consequences of an assault on their dignity, honor and self-esteem, in addition to physical and mental injuries, should also be considered (Rev Méd Chile 2005; 133: 841-6).
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceRevista Medica de Chile
dc.subjectContraceptives, Postcoital
dc.subjectEthics, Medical
dc.subjectLevonorgestrel
dc.titleBioethical issues involved in the prescription of levonorgestrel Levonorgestrel: Aspectos bioéticos implicados en su indicación y proscripción
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución